BeStock  
Stocks › Medical Devices › CTKB

Cytek Biosciences CTKB

US equityMarket cap rank #3306Medical Devices
$6.12 −$0.20 (-3.16%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.12 0.00%
Open$6.31
Prev close$6.32
Day range$5.99 – $6.39
Volume1.77M
Market cap$800.40M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership64.7%+0.91 pts vs. prior quarter
Institutions holding187+1 vs. prior quarter
Insider trades (recent)37 buys / 13 sellsNet buying
Short interest3.16% of floatDays to cover 3.6 · as of 30 Oct 2026
Short-sale volume share15.4%5-day average of daily volume

Short-sale volume as % of daily volume

9%16%24%31%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.17M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$313.8KSuper−$852.9KBig−$350.8KMid+$1.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 29.8% of shares outstanding.

Largest holders

  • BlackRock9.32%
  • Millennium Management LLC5.57%
  • Hillhouse Capital Management, Ltd.5.09%
  • Boston Partners Global Investors, Inc.4.99%
  • Topline Capital Management, LLC4.80%
  • Wenbin Jiang4.25%
  • Vanguard Capital Management, LLC3.74%
  • Ming Yan3.69%

By investor type

  • Mutual Fund40.90%
  • Hedge Fund14.99%
  • Individual/Insider8.43%
  • VC/PE Fund5.09%
  • Private Company1.88%
  • Public Company1.45%
  • Insurance Company0.20%
  • Government Pension Fund0.17%

Reported short interest has fallen from 3.84% to 3.16% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +2,606,585 9.3%
Acadian Asset Management LLC Mutual Fund 2026/Q3 +1,342,842 2.1%
Russell Investment Management, LLC Mutual Fund 2026/Q3 +917,432 1.9%
Connor, Clark & Lunn Investment Management Ltd. Mutual Fund 2026/Q3 +308,052 0.4%
Mackenzie Financial Corporation Mutual Fund 2026/Q3 +305,136 0.2%
Martingale Asset Management, L.P. Mutual Fund 2026/Q3 +258,385 0.2%
UBS Asset Management Mutual Fund 2026/Q3 +254,549 0.3%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +215,105 0.3%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +257,085 0.2%
Millennium Management LLC Hedge Fund 2026/Q3 +3,046,212 7.2%
Boston Partners Global Investors, Inc. Mutual Fund 2026/Q3 +1,832,372 5.9%
Acadian Asset Management LLC Mutual Fund 2026/Q3 +977,060 1.1%
Jane Street Group, LLC Private Company 2026/Q3 +906,162 0.7%
Qube Research & Technologies Ltd Mutual Fund 2026/Q3 +689,821 0.5%
Arrowstreet Capital, Limited Partnership Mutual Fund 2026/Q3 +653,924 0.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
8 Nov 2026 Ilan Feuchtwang Other Derivative Acquisition +25,745 – 25,745
1 Sep 2026 Philippe Busque Former Senior Vice President of Global Sales & Services Intent to Sell (Form 144) -31,666 $4.63 –
17 Aug 2026 Glenn Muir Independent Director Derivative Exercise and Retained +3,086 – 3,086
17 Aug 2026 Richard Chin Independent Director Derivative Exercise and Retained +6,107 – 28,499
17 Aug 2026 Michael Holder Independent Director Derivative Exercise and Retained +2,181 – 62,875
17 Aug 2026 William McCombe Chief Financial Officer Derivative Exercise and Sale -11,904 $4.67 134,693
17 Aug 2026 William McCombe Chief Financial Officer Derivative Exercise and Retained +23,516 – 134,693
17 Aug 2026 Wenbin Jiang Chairperson & CEO Derivative Exercise and Sale -36,269 $4.67 5,561,029
17 Aug 2026 Wenbin Jiang Chairperson & CEO Derivative Exercise and Retained +83,826 – 5,561,029
17 Aug 2026 Ming Yan CTO & Director Derivative Exercise and Sale -8,088 $4.67 4,821,870
17 Aug 2026 Ming Yan CTO & Director Derivative Exercise and Retained +25,182 – 4,821,870
9 Aug 2026 Ilan Feuchtwang Other Derivative Acquisition +127,118 $4.66 127,118
9 Aug 2026 Ilan Feuchtwang Other Derivative Acquisition +241,416 – 241,416
11 Jun 2026 Ming Yan CTO & Director Other Disposition -135,892 – 4,796,688
9 Jun 2026 Deborah Neff Lead Independent Director Other Derivative Acquisition +18,261 $4.05 18,261
9 Jun 2026 Deborah Neff Lead Independent Director Other Derivative Acquisition +33,333 – 33,333
9 Jun 2026 Deborah Neff Lead Independent Director Derivative Exercise and Retained +43,973 – 59,679
9 Jun 2026 Glenn Muir Independent Director Other Derivative Acquisition +29,835 $4.05 29,835
9 Jun 2026 Glenn Muir Independent Director Other Derivative Acquisition +55,555 – 55,555
9 Jun 2026 Jack Ball Former Independent Director Derivative Exercise and Retained +43,973 – 86,678

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 4,105,921 3.2% 3.6
15 Oct 2026 4,409,745 3.4% 2.7
30 Sep 2026 5,215,595 4.0% 3.1
15 Sep 2026 5,242,079 4.0% 5.7
31 Aug 2026 4,931,028 3.8% 6.6
14 Aug 2026 4,989,610 3.8% 5.1

Discussion

No comments yet — be the first to weigh in on CTKB.

Sign in to join the discussion.

Scroll to Top